Cargando…
Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial
Objective To assess the impact of prophylactic oral co-trimoxazole in reducing mortality in HIV positive Zambian adults being treated for pulmonary tuberculosis. Design Double blind placebo controlled randomised clinical trial. Participants Two groups of antiretroviral treatment naive adults with HI...
Autores principales: | Nunn, Andrew J, Mwaba, Peter, Chintu, Chifumbe, Mwinga, Alwyn, Darbyshire, Janet H, Zumla, Alimuddin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656923/ https://www.ncbi.nlm.nih.gov/pubmed/18617486 http://dx.doi.org/10.1136/bmj.a257 |
Ejemplares similares
-
Childhood Tuberculosis and Infection with the Human Immunodeficiency Virus
por: Chintu, Chifumbe, et al.
Publicado: (1995) -
Comparison of the effect of co-trimoxazole and co-trimoxazole plus ciprofloxacin in urinary tract infection prophylaxis in kidney transplant patients
por: Khorvash, Farzin, et al.
Publicado: (2016) -
Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort
por: Walker, AS, et al.
Publicado: (2010) -
Co‐trimoxazole prophylaxis for children who are HIV‐exposed and uninfected: a systematic review
por: Wedderburn, Catherine J., et al.
Publicado: (2023) -
Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial
por: Sandison, Taylor G, et al.
Publicado: (2011)